We are live on
!
Find out more
RC
Rexford Capital Portfolio holdings
AUM
$140M
1-Year Est. Return
28.19%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+28.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$114M
Cap. Flow
% of AUM
94.29%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
280
New
280
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$3.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$3.08M |
| 3 |
Apple
AAPL
|
+$2.76M |
| 4 |
KLA
KLAC
|
+$2.4M |
| 5 |
NVIDIA
NVDA
|
+$2.33M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Financials | 15.44% |
| 3 | Industrials | 12.38% |
| 4 | Healthcare | 11.42% |
| 5 | Consumer Staples | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Thor Industries
THO
$3.98B
| $167K | 0.14% |
+1,875
| New | +$148K |
|
177
Zoetis
ZTS
$32.2B
| $165K | 0.14% |
+1,060
| New | +$168K |
|
178
HSBC
HSBC
$357B
| $165K | 0.14% |
+2,713
| New | +$154K |
|
179
Idexx Laboratories
IDXX
$43.9B
| $164K | 0.14% |
+305
| New | +$146K |
|
180
Campbell Soup
CPB
$6.67B
| $163K | 0.14% |
+5,330
| New | +$188K |
|
181
Humana
HUM
$45.8B
| $163K | 0.14% |
+666
| New | +$166K |
|
182
Halliburton
HAL
$26.8B
| $161K | 0.13% |
+7,894
| New | +$166K |
|
183
Prologis
PLD
$137B
| $158K | 0.13% |
+1,500
| New | +$157K |
|
184
MiMedx Group
MDXG
$635M
| $153K | 0.13% |
+25,024
| New | +$166K |
|
185
Monster Beverage
MNST
$93.2B
| $153K | 0.13% |
+2,440
| New | +$149K |
|
186
Align Technology
ALGN
$12B
| $151K | 0.13% |
+800
| New | +$141K |
|
|
SCHW
187
Charles Schwab
SCHW
$181B
| $151K | 0.13% |
+1,651
| New | +$138K |
|
188
Adobe
ADBE
$94.5B
| $147K | 0.12% |
+379
| New | +$146K |
|
189
Best Buy
BBY
$18.6B
| $146K | 0.12% |
+2,181
| New | +$148K |
|
190
Universal Health Services
UHS
$9.64B
| $145K | 0.12% |
+800
| New | +$144K |
|
191
Regeneron Pharmaceuticals
REGN
$69.9B
| $143K | 0.12% |
+273
| New | +$152K |
|
192
Takeda Pharmaceutical
TAK
$55.7B
| $143K | 0.12% |
+9,233
| New | +$136K |
|
|
NVMI
193
Nova
NVMI
$13.6B
| $138K | 0.11% |
+500
| New | +$102K |
|
194
MarketAxess Holdings
MKTX
$4.19B
| $137K | 0.11% |
+614
| New | +$135K |
|
195
DuPont de Nemours
DD
$18.9B
| $136K | 0.11% |
+1,585
| New | +$132K |
|
196
D.R. Horton
DHI
$41.3B
| $131K | 0.11% |
+1,020
| New | +$126K |
|
197
Enbridge
ENB
$121B
| $131K | 0.11% |
+2,900
| New | +$132K |
|
|
NVO
198
Novo Nordisk
NVO
$220B
| $130K | 0.11% |
+1,886
| New | +$128K |
|
199
Edgewell Personal Care
EPC
$1.28B
| $130K | 0.11% |
+5,535
| New | +$153K |
|
200
James Hardie Industries
JHX
$15.5B
| $129K | 0.11% |
+4,800
| New | +$116K |
|
Similar funds
CPC
JD6
MWM
WCM
VEM
SM
SCM
GIM
Rexford Capital's Q2 2025 Portfolio in Review
Q2 2025 is the first quarter with a 13F filing on record for Rexford Capital, which disclosed 280 positions worth $121M. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Berkshire Hathaway Class B: 6,687 shares worth $3.25M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, followed by Financials and Industrials.
- Rexford Capital's largest Q2 2025 buy was Berkshire Hathaway Class B: 6,687 shares worth $3.25M.
- Rexford Capital's ten largest holdings make up 21% of its $121M portfolio in Q2 2025.
- Rexford Capital disclosed 280 positions in Q2 2025, its first 13F filing on record.
Based on Rexford Capital's 13F filing for Q2 2025, filed 18 Aug 2025.